KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gilead Sciences (GILD) Tax Provisions (2016 - 2026)

Gilead Sciences filings provide 17 years of Tax Provisions readings, the most recent being -$450.0 million for Q4 2025.

  • On a quarterly basis, Tax Provisions fell 216.88% to -$450.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $941.0 million, a 345.97% increase, with the full-year FY2025 number at $1.3 billion, up 509.48% from a year prior.
  • Tax Provisions hit -$450.0 million in Q4 2025 for Gilead Sciences, down from $589.0 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $852.0 million in Q3 2021 to a low of -$450.0 million in Q4 2025.
  • Median Tax Provisions over the past 5 years was $375.5 million (2021), compared with a mean of $286.2 million.
  • Biggest five-year swings in Tax Provisions: plummeted 303.42% in 2024 and later surged 298.32% in 2025.
  • Gilead Sciences' Tax Provisions stood at $383.0 million in 2021, then rose by 3.92% to $398.0 million in 2022, then plummeted by 40.45% to $237.0 million in 2023, then surged by 62.45% to $385.0 million in 2024, then plummeted by 216.88% to -$450.0 million in 2025.
  • The last three reported values for Tax Provisions were -$450.0 million (Q4 2025), $589.0 million (Q3 2025), and $468.0 million (Q2 2025) per Business Quant data.